Level Biotechnology

Level Biotechnology EBITDA per Share

The EBITDA per Share of Level Biotechnology (3118.TWO) as of Oct 15, 2026 is 2.60 TWD. In the previous year, EBITDA per Share was 2.34 TWD — a change of 10.98% (higher).

EBITDA per Share

2.60TWD

YoY

10.98%

Last updated:

EBITDA per Share of Level Biotechnology is 2025 2.60 TWD. EBITDA per Share of Level Biotechnology was 2024 2.34 TWD. It decreases by 10.98% higher compared to the previous year.

The Level Biotechnology EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
1.53 TWD
Jan 1, 2019
1.76 TWD
Jan 1, 2020
2.25 TWD
Jan 1, 2021
2.63 TWD
Jan 1, 2022
2.26 TWD
Jan 1, 2023
2.43 TWD
Jan 1, 2024
2.34 TWD
Jan 1, 2025
2.60 TWD
The Level Biotechnology EBITDA per Share history
YEAREBITDA per ShareYoY
2.60TWD+10.98%
2.34TWD-3.62%
2.43TWD+7.40%
2.26TWD-13.93%
2.63TWD+16.77%
2.25TWD+28.16%
1.76TWD+14.81%
1.53TWD-39.15%
2.52TWD+10.20%
2.28TWD-12.79%
2.62TWD-3.69%
2.72TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Level Biotechnology Stock analysis

What does Level Biotechnology do? Level Biotechnology Inc is a company based in Taipei, Taiwan, operating within the Health Care sector. It went public on September 10, 2004, with its ticker symbol 3118.TWO and ISIN TW0003118006. The company provides biotechnological services, focusing on products such as cell culture series, immune protein series, gene nucleic acid and molecular biology series, and instrument series. Additionally, Level Biotechnology offers preclinical testing services, including genetic toxicity testing, general toxicology testing, reproductive toxicology testing, pharmacokinetic testing, and biocompatibility testing. The company's website is https://www.level.com.tw/index_tw.php. Level Biotechnology operates primarily in the domestic market, serving clients within Taiwan. It is headquartered in Taipei, New Taipei, as stated in the provided information. The company's services and products are designed to support research and development in the biotechnology and health care fields. No additional details about founding year, key personnel, acquisitions, or specific financial figures are provided in the given data. The company's activities are centered around delivering specialized biotechnological solutions to its market. Level Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Level Biotechnology stock

EBITDA per Share of Level Biotechnology is 2.60 TWD in 2025.

EBITDA per Share of Level Biotechnology changed from 2.34 TWD to 2.60 TWD, representing a 10.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Level Biotechnology since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Level Biotechnology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Level Biotechnology